SPC455
Elacestrant eða salt þar af
Status:
UmsóknApplication date:
1.3.2024Application published:
15.4.2024
Max expiry date:
14.9.2038Medicine name:
OrserduMedicine for children:
No
Timeline
Today
1.3.2024Application
15.4.2024Publication
14.9.2038Expires
Marketing license
IS authorization number:
EU/1/23/1757Date:
19.10.2023
Foreign authorization number:
EU/1/23/1757Date:
15.9.2023
Owner
Name:
Duke UniversityAddress:
2812 Erwin Road, Suite 306, Durham, NC 27705 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3122426